Feb
21
Graduate Program – Product Innovation
February 21, 2023 | Comments Off on Graduate Program – Product Innovation
Graduate Program - Product Innovation
To start in April 2023
Based in Basildon, Essex or London
Salary: Competitive + Benefits + Bonus
If you are inquisitive, an out of the box thinker with a keen interest in exploring the today and tomorrow of emerging unmet therapeutic areas in Cardiovascular, Oncology, Endocrinology and Neurology, then we want to hear from you!
Do you enjoy spotting patient needs, unlocking the full potential of new and existing therapies, interpreting why doctors and patients act the way they do, understanding the pharmaceutical sales value chain and applying this to clinical and commercial strategies to help shape successful pharma brands of the future?
Join us to help improve peoples' lives and make healthcare better for everyone!
Why Pharmanovia?
Pharmanovia is a dynamic, fast-growing international pharmaceutical company with a portfolio of over 20 brands across more than 140 markets. Our mission is to improve patient health globally through the revitalisation of niche, tried-and-trusted medicines.
Since its inception in 2013, Pharmanovia has grown consistently year on year, focusing on delivering high-quality branded prescription medicines to patients, prescribers and healthcare providers across the world. Our growth has enabled the company to reinvest in its products, brands, people, and to give back to its communities. A people business with a strong, supportive culture that encourages innovation and entrepreneurial spirit, our team comprises over 300 employees and 29 nationalities, operating from offices in the UK, Denmark, Netherlands, Switzerland, U.A.E., India, Singapore, Italy, and South Korea.
We are an agile and imaginative global specialty pharma business and a preferred partner for innovator pharma companies, instigating a paradigm shift in the life cycle management of iconic medicines. We seek to extensively engage with clinical communities to communicate product improvements and prioritise environmental, social, and governance considerations across the business and workforce.
Pharmanovia's therapeutic areas include Cardiovascular, Oncology, Endocrinology and Neurology.
Our Graduate Scheme:
You'll be joining a supportive team and this is a great opportunity for individual learning and career progression. The department has an ethos of continuous drug innovation through life cycle management, adding value to the Pharmanovia iconic brands and creating efficiencies. This, along with the rapid growth of the business, leads to a varied and dynamic working environment.
You will be learning and be responsible for high-quality analyses across a broad range of diseases and main conditions in the Pharmanovia therapy areas. Your core objectives include conducting research to create insightful commentary on the present and future drug landscape.
The role will report directly into the Associate Vice-President for Global Product Innovation and the successful candidate will be involved in:
- Conducting systematic literature reviews and analyse databases to identify prevalence/incidence data for assigned disease-specific conditions.
- Analysing health conditions using treatment guidelines, regulatory, patent and clinical databases and publicly available sources for patient pool, licensed and un-licensed treatment options and unmet treatment needs.
- Developing knowledge of the pharmaceutical marketplace of IQVIA data.
- Learning new ways of analysing historical trends and patient / clinical reviews to estimate unmet needs.
- Producing regular updates of a specific subset of diseases and/or therapy areas.
- Compiling insightful and well-supported analysis.
About you:
Success in this role will require excellent time management and strong analytical skills. You will also need to have:
- Minimum 2.1 degree in a relevant subject (e.g., Life & Health sciences, Data sciences, Quantitative disciplines, Chemistry, Economics, Business Studies, Computing, statistics)
- Strong aptitude for technology and highly proficient in the use of MS Office particularly intermediate to advanced Excel and PowerPoint
- First class numerical and analytical skills
- Excellent standard of written and verbal communication in business English
- Ability to relate to stakeholders at all levels and from different cultural backgrounds
- Flexibility to align to the working requirements of a fast-paced Graduate scheme
- Relevant work experience by the way of placement would be desirable, but not essential
- Demonstrable evidence of problem-solving
- Project management skills
- Organisational skills
What we offer:
We offer a competitive salary and rewards package including holiday, health & wellbeing program, employee recognition awards, social events, pension scheme and hybrid working.
To apply please submit your CV. Shortlisted applicants will be invited to interview in March. The program starts in April 2023.
We'll support anyone who requires reasonable adjustments to their application process.
We believe that everyone, irrespective of their background, should be able to achieve their full potential. Supporting social mobility is one of our priorities and we've been working hard to help, we are aligning our attraction and recruitment activities to engage with a broader range of applicants. if you would like to submit a supporting statement or complete our contextual recruitment questionnaire please - just let us know. The questionnaire is optional. It is a tool that we hope will help us as an employer to understand any barriers that you have overcome, allowing for a fairer assessment of your abilities.
Please note: You must already have the right to work in the UK. We are unable to provide sponsorship or work visas at this time.
By applying for this role, your details will be sent to Ortolan People, who are engaged to provide recruitment support in processing applications. We will endeavour to respond to all applicants within three working days. Occasionally for roles with a very high volume of applicants, this may not be possible.